J&J | JNJ - Equity Capital And Reserves



J&J reported $78.11B in Equity Capital and Reserves for its fiscal quarter ending in March of 2025.


Equity Capital And Reserves Change Date
AbbVie USD 1.46B 1.86B Mar/2025
Abbott USD 50.83B 1.76B Jun/2025
Amgen USD 7.43B 1.22B Jun/2025
AstraZeneca USD 44.72B 3.68B Jun/2025
Baxter International USD 7.05B 90M Mar/2025
Bayer EUR 30.5B 2.08B Jun/2025
Becton, Dickinson and Co. USD 25.47B 231M Jun/2025
Biogen USD 17.63B 655.3M Jun/2025
Boston Scientific USD 22.21B 443M Mar/2025
Bristol-Myers Squibb USD 17.49B 100M Jun/2025
CONMED USD 1B 25.23M Jun/2025
Cooper Companies USD 8.35B 64.9M Jul/2025
Dexcom USD 2.57B 306.5M Jun/2025
Edwards Lifesciences USD 10.19B 193.2M Mar/2025
Eli Lilly USD 18.27B 2.43B Jun/2025
Gilead Sciences USD 19.67B 596M Jun/2025
GlaxoSmithKline GBP 14.35B 197M Jun/2025
Globus Medical USD 4.3B 207.61M Jun/2025
Hologic USD 4.84B 223.8M Jun/2025
Insulet USD 1.46B 132.2M Jun/2025
Integra LifeSciences USD 1.04B 485.48M Jun/2025
Intuitive Surgical USD 17.95B 745.4M Jun/2025
J&J USD 78.11B 6.62B Mar/2025
Medtronic USD 48.02B 1.36B Apr/2025
Merck USD 49.06B 725M Jun/2025
Merit Medical Systems USD 1.49B 59.62M Jun/2025
Novartis USD 42.05B 3.6B Jun/2025
Pfizer USD 88.7B 1.64B Jun/2025
Regeneron Pharmaceuticals USD 29.94B 551.3M Jun/2025
Roche Holding CHF 36.16B 3.28B Dec/2024
Sanofi 70.28B 3.8B Jun/2025
Stryker USD 21.19B 261M Jun/2025
Tandem Diabetes Care USD 133.28M 22.01M Jun/2025
Teva Pharmaceutical Industries USD 6.83B 572M Jun/2025
Vertex Pharmaceuticals USD 17.18B 679.1M Jun/2025
Zimmer Biomet Holdings USD 12.53B 130.5M Jun/2025
Zoetis USD 4.98B 322M Jun/2025